CryoPort announces closure of $5.0M private placement

CryoPort, Inc. (OTCBB: CYRX) today announced it has closed a private placement with various accredited investors for gross proceeds of $5.0 million. The Company obtained agreements to purchase 9,119,100 shares of common stock at $0.55 per share. For each share of common stock purchased, investors will receive a warrant to purchase one share of common stock at an exercise price of $0.69 per share, pursuant to a Securities Purchase Agreement.

The Company intends to use the proceeds of the private placement for working capital purposes.

Craig-Hallum Capital Group LLC served as the Company's placement agent for the transaction and Emergent Financial Group, Inc. as co-placement agent.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.